Sort   by:  
 Page size 
UnknownNew Agents, Emerging Late Effects, and the Development of Precision Survivorship.
Not available
S-EPMC6053298 | biostudies-literature
UnknownPatient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.
Not available
S-EPMC7137289 | biostudies-literature
UnknownEverolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.
Not available
S-EPMC5950503 | biostudies-literature
UnknownPhase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Not available
S-EPMC6075847 | biostudies-literature
UnknownAPOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.
Not available
S-EPMC8980930 | biostudies-literature
Sort   by:  
 Page size